{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000071","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.834293+00:00","generated_at":"2026-06-01T09:33:43.742588+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Lifecore CEO James Hall resigns; Paul Josephs appointed CEO and director effective May 20","bullets":["James G. Hall resigned as director, President and CEO effective May 19, 2024.","Paul Josephs appointed President, CEO and director effective May 20, 2024.","Josephs previously CEO of Woodstock Sterile Solutions (CDMO) from April 2021 to May 2024.","Granted 525,000 RSUs (25k vested immediately, 100k/year over 5 years) and up to 1.5M PSUs with performance price targets from $7.50 to $35.00 per share.","Josephs enters Tier 1 Change in Control Severance Plan benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000071","json":"https://secwatch.observer/filing/0001005286-24-000071.json","markdown":"https://secwatch.observer/filing/0001005286-24-000071.md","text":"https://secwatch.observer/filing/0001005286-24-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/lndc-20240519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:33:43.742588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6d629bd1eb","claim":"James G. Hall resigned as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"Effective May 19, 2024, James G. Hall resigned as a director of the Company and ceased serving as the Company’s President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"f271c912e4","claim":"Paul Josephs was appointed as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On May 20, 2024, Paul Josephs began serving as the Company’s President and Chief Executive Officer and was elected as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}